Teva acquires Emalex Biosciences for up to $900m
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) today announced it has signed a definitive agreement to acquire Emalex ...
Monday, May 25, 2026
Tag: Teva
Teva Pharmaceuticals – TEVA: Abschied vom Generika-Geschäft! Was nun?
Strategische Neuausrichtung! Pullback-Setup bei der Teva-Aktie! Kommt der Bounce nach 7 roten Kerzen? Quartalszahlen erst im Mai! Teva Pharmaceuticals (TEVA) ...
Teva sees lower revenue and profit in 2026
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) ended 2025 with revenue of $17.3 billion, up 4% from $16.5 ...
Teva collaborates on skin disease treatment, releases targets
Teva Pharmaceutical Industries (TASE: TEVA; NYSE: TEVA) published two positive announcements yesterday. The first concerns collaboration with Royalty Pharma ...
Teva beats analysts on Q3, raises guidance
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has presented strong third quarter results and calmed investors. Despite concerns, ...
Teva jumps ahead of Q3 results
The share price of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) rose 8.1% last week on Wall Street, ...
Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory
We came across a bullish thesis on Teva Pharmaceutical Industries Limited on Kontra Investments’s Substack by Kontra. In this article, ...
- Trending
- Comments
- Latest
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.